The monoamine oxidases of brain: selective inhibition with drugs and the consequences for the metabolism of the biogenic amines.
D000480:Alkynes / Q000494:pharmacology; D000818:Animals; D001679:Biogenic Amines / Q000378:metabolism*; D001921:Brain / Q000166:cytology / Q000201:enzymology* / Q000378:metabolism; D002250:Carbon Radioisotopes; D003342:Corpus Striatum / Q000378:metabolism; D003641:Deamination; D004295:Dihydroxyphenylalanine / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D006897:Hydroxyindoleacetic Acid / Q000378:metabolism; D066298:In Vitro Techniques; D008297:Male; D008928:Mitochondria / Q000378:metabolism; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D009638:Norepinephrine / Q000378:metabolism; D010627:Phenethylamines / Q000378:metabolism / Q000494:pharmacology; D010647:Phenyl Ethers / Q000494:pharmacology; D011437:Propylamines / Q000494:pharmacology; D051381:Rats; D012701:Serotonin / Q000378:metabolism; D013997:Time Factors
D000480:Alkynes; D001679:Biogenic Amines; D002250:Carbon Radioisotopes; D008996:Monoamine Oxidase Inhibitors; D010627:Phenethylamines; D010647:Phenyl Ethers; D011437:Propylamines; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D004295:Dihydroxyphenylalanine; D004298:Dopamine; D009638:Norepinephrine